Evidence map›Paper›PMID 25173174›Full record

ArticleNature structural & molecular biology2014

TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release.

Heeyoun Bunch, Xiaofeng Zheng, Adam Burkholder, Simon T Dillon, Shmulik Motola, Gabriel Birrane, Christopher C Ebmeier, Stuart Levine, David Fargo, Guang Hu and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. The CTNNB1-TRIM28 complex governs hormone-induced RNA polymerase II dynamics in kidney epithelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. DNA topological regulation in RNA polymerase II transcription.Cellular & molecular biology letters · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Secrets of DNA-PKcs beyond DNA repair.NPJ precision oncology · 2024
    Review
  18. Article
  19. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA mJournal of experimental & clinical cancer research : CR · 2024
    Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Heeyoun BunchDepartment of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000000300381985
Xiaofeng Zheng1] Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA. [2].
Adam Burkholder1] Integrative Bioinformatics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA. [2].
Simon T Dillon1] Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. [2] Genomics and Proteomics Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Shmulik MotolaBioMicro Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Gabriel Birrane1] Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Christopher C EbmeierDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, Boulder, Colorado, USA.
Stuart LevineBioMicro Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
David FargoIntegrative Bioinformatics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Guang HuLaboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Dylan J TaatjesDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, Boulder, Colorado, USA.
Stuart K CalderwoodDepartment of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000000199663354
Beth Israel Deaconess Medical Center · USNational Institutes of Health · USMassachusetts Institute of Technology · USUniversity of Colorado Boulder · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Role of Pluripotency Factors in Pluripotent Stem Cells, Development and DiseaseZIAES102745 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI HU, GUANG · 2010 to 2025
$31.5M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
TRANSMEMBRANE SIGNAL MODULATION BY HYPERTHERMIAR01CA047407 · NCI · DANA-FARBER CANCER INSTITUTE · PI CALDERWOOD, STUART KEITH · 1988 to 2014
$4.3M
Mechanistic Studies of Mediator and the p53 Tumor SuppressorR01CA127364 · NCI · UNIVERSITY OF COLORADO · PI TAATJES, DYLAN J · 2007 to 2011
$1.1M
Intramural NIH HHS ZIA ES102745NCI NIH HHS P30 CA014051NCI NIH HHS R01 CA047407NCI NIH HHS R0-1CA047407NCI NIH HHS R01 CA127364NCI NIH HHS R01CA127364NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30-ES002109
6 · The paper itself

Abstract

Promoter-proximal pausing of RNA polymerase II (Pol II) is a major checkpoint in transcription. An unbiased search for new human proteins that could regulate paused Pol II at the HSPA1B gene identified TRIM28. In vitro analyses indicated HSF1-dependent attenuation of Pol II pausing upon TRIM28 depletion, whereas in vivo data revealed de novo expression of HSPA1B and other known genes regulated by paused Pol II upon TRIM28 knockdown. These results were supported by genome-wide ChIP-sequencing analyses of Pol II occupancy that revealed a global role for TRIM28 in regulating Pol II pausing and pause release. Furthermore, in vivo and in vitro mechanistic studies suggest that transcription-coupled phosphorylation regulates Pol II pause release by TRIM28. Collectively, our findings identify TRIM28 as a new factor that modulates Pol II pausing and transcriptional elongation at a large number of mammalian genes.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell Line, TumorDNA-Activated Protein KinaseDNA-Binding ProteinsHeat Shock Transcription FactorsHEK293 CellsHeLa CellsHSP70 Heat-Shock ProteinsHumansPhosphorylationPromoter Regions, GeneticRepressor ProteinsRNA Polymerase IITranscription FactorsTranscription, GeneticTripartite Motif-Containing Protein 28Ataxia Telangiectasia Mutated ProteinsATM protein, humanDNA-Activated Protein KinaseDNA-Binding ProteinsHeat Shock Transcription FactorsHSF1 protein, humanHSP70 Heat-Shock ProteinsHSPA1B protein, humanRepressor ProteinsRNA Polymerase IITranscription FactorsTRIM28 protein, humanTripartite Motif-Containing Protein 28

Identifiers

PMID25173174
PMCPMC4189995
OpenAlexW2018134526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.